SCHEMBL24178010

SCHEMBL24178010

CNCCNCc1ccc(C(=O)O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
KMT2A Q03164 4/20 0.56
NR1H4 Q96RI1 3/20 0.47
EPHX2 P34913 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SRD5A2 P31213 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
S1PR2 O95136 1/20 0.45
S1PR1 P21453 1/20 0.45
S1PR3 Q99500 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2938207 0.91 ALDH1A1 (0.69) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2
Terephthalic Acid SCHEMBL11033093 0.84 TSHR (0.60) ALDH1A1KMT2ASMN1; SMN2SRD5A2HPGD
SCHEMBL28423573 0.84 ALDH1A1 (0.57) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2
SCHEMBL249385 0.83 KMT2A (0.66) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2
SCHEMBL3503996 0.82 ALDH1A1 (0.81) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2
SCHEMBL7723455 0.82 ALDH1A1 (0.59) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2
Hydrochloric Acid SCHEMBL944164 0.81 KMT2A (0.63) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2
SCHEMBL7721622 0.81 ALDH1A1 (0.57) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2
SCHEMBL18828911 0.81 S1PR1 (0.57) ALDH1A1KMT2ASMN1; SMN2MEN1S1PR2
SCHEMBL7721679 0.81 ALDH1A1 (0.57) ALDH1A1KMT2ANR1H4EPHX2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002287-A1 INDAZOLE KINASE INHIBITOR AND USE THEREOF Tarapeutics Science Inc. (CN) 2022-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002287-A1 INDAZOLE KINASE INHIBITOR AND USE THEREOF FLT3, FGFR1, FLT1 ALDH1A1 1239/4885KMT2A 1434/4885NR1H4 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.